FindTrial
Sign In

A single institutional study on clinicopathological profile of early bladder cancer

Clinicopathological profile of non muscle invasive bladder cancer: A prospective, single institutional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/11/016426
Enrollment
100
Registered
2018-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to Kasturba Medical College, Manipal with a diagnosis of non muscle invasive bladder cancer.

Exclusion criteria

Exclusion criteria: Patients with stage T2 or more

Design outcomes

Primary

MeasureTime frame
To study the demographics, various risk factors and clinical presentations of NMIBC. To evaluate accuracy of various diagnostic modalities and efficacy of various treatment modalities. To evaluate the management of BCG resistant/failure/relapse cases.Timepoint: At initial evaluation and as per serial follow up visits at 3 monthly intervals—

Secondary

MeasureTime frame
To evaluate role of Neutrophil: Lymphocyte ratio as a prognostic indicator.Timepoint: At initial evaluation and as per serial follow up visits at 3 monthly intervals;To study utility of EORTC and CUETO risk scoring methods for predicting progression/recurrence.Timepoint: At initial evaluation and as per serial follow up visits at 3 monthly intervals—

Countries

India

Contacts

Public ContactDr Varun Laddha

Kasturba Medical College, Manipal

drjosephthomas@yahoo.co.in9945272294

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026